Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08754.x/fullpdf
Reference10 articles.
1. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party;Augustson;Journal of Clinical Oncology,2005
2. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial;Clark;Annals of Internal Medicine,2005
3. Pathogenesis and treatment of renal failure in multiple myeloma;Dimopoulos;Leukemia,2008
4. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group;Dimopoulos;Journal of Clinical Oncology,2009
5. Metabolism and mechanisms of action of bendamustine: rationales for combination therapies;Gandhi;Seminars in Oncology,2002
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment;Critical Reviews in Oncology/Hematology;2023-03
2. What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma;Targeted Oncology;2022-06-30
3. Current and Novel Alkylators in Multiple Myeloma;Cancers;2021-05-18
4. Monoclonal gammopathy of renal significance: clinical manifestation, pathogenic characteristic and treatment;Panminerva Medica;2020-03
5. Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib;British Journal of Haematology;2018-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3